NCT00047710 - Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Pancreatic Cancer

Interventions

DRUG

Bevacizumab

Beginning 2 weeks prior to radiotherapy, dose of 5 mg/kg by vein then of 2.5 mg/kg during radiotherapy for four weeks every 2 weeks (three doses).

DRUG

Capecitabine

650mg/m\^2 taken by mouth twice a day 15-52 during the radiotherapy.

RADIATION

Radiotherapy

Radiography given once a day for 5 days at 50.4 Gy in 28 fractions over 5.5 weeks.

Trial Locations (1)

University of Texas MDAnderson Cancer Center, Houston